Showing results (231-240 of 297) with videos related to
Sort By:
Pageof 30
Endocrine Connections|January 11, 2022
Cardio-psycho-metabolic outcomes of bariatric surgery: design and baseline of the WAS trialAnn-Cathrin Koschker, Bodo Warrings, Caroline Morbach, et al.Cancers|April 23, 2022
Sorafenib Versus Lenvatinib-Based Sequential Systemic Therapy for Advanced Hepatocellular Carcinoma: A Real-World AnalysisCatherine Leyh, Ursula Ehmer, Daniel Roessler, et al.Scandinavian Journal of Gastroenterology|October 2, 2018
Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot studyAndreas Geier, Mareile Eichinger, Guido Stirnimann, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2022
Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pumpGuido Stirnimann, Thomas Berg, Laurent Spahr, et al.Zeitschrift Fur Gastroenterologie|May 15, 2025
Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-RegistryEva Katharina Messer, David Petroff, Jörn Schattenberg, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|June 28, 2014
Downregulation of duodenal SLC transporters and activation of proinflammatory signaling constitute the early response to high altitude in humansKacper A Wojtal, Alexandra Cee, Silvia Lang, et al.Journal of Cancer Research and Clinical Oncology|July 21, 2022
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective studyDaniel Roessler, Osman Öcal, Alexander B Philipp, et al.Clinical Science (London, England : 1979)|October 2, 2010
A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver diseaseRika Iwata, Katharina Baur, Bruno Stieger, et al.American Journal of Physiology. Endocrinology and Metabolism|July 29, 2026
PYY3-36 potentiates Semaglutide‑mediated mitochondrial modulation in MASLDNiklas Geiger, Alexander Georg Nickel, Michael Kohlhaas, et al.Hepatology (Baltimore, Md.)|June 22, 2013
Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineersOliver Goetze, Johannes Schmitt, Kerstin Spliethoff, et al.Pageof 30